Theraplix

Theraplix is a French pharmaceutical company that was established in 1921. It is known for its contributions to the field of dermatology and endocrinology.

History

Theraplix was founded in 1921 by Dr. Henri Laborit, a French physician and neurobiologist. The company initially focused on the production of iodine-based products, which were used in the treatment of various skin conditions.

In the 1950s, Theraplix expanded its focus to include endocrinology. The company developed a number of innovative treatments for thyroid disorders, including the first synthetic thyroxine.

Products

Theraplix's product line includes treatments for a variety of skin and endocrine conditions. Some of their notable products include:

• Elteans: A dietary supplement designed to improve skin health.
• Fluasterone: A synthetic steroid used in the treatment of adrenal insufficiency.
• Thyroxine (T4): A synthetic version of the thyroid hormone thyroxine.

Research and Development

Theraplix has a strong commitment to research and development. The company collaborates with researchers and clinicians worldwide to develop new treatments and improve existing ones. Their research focuses on understanding the underlying mechanisms of skin and endocrine disorders, with the goal of developing more effective treatments.

See Also

• Pharmaceutical Industry in France
• List of Pharmaceutical Companies

References

   This article is a French corporation or company stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!